U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313592) titled 'Whole Genome Sequencing (ChromoSeq(R)) for Acute Lymphoblastic Leukemia (ALL) Patients' on Dec. 17, 2025.
Brief Summary: This is a prospective specimen collection study evaluating the feasibility of using the ChromoSeq(R) assay for upfront classification in a real-time clinical setting of pediatric and young adult acute lymphoid leukemia (ALL) patients. Sixty patients will undergo collections of bone marrow and/or peripheral blood for the ChromoSeq(R) assay at time of initial workup, and the patients will then be followed for clinical outcomes for up to 65 months.
Study Start Date: Jan. 31
Study Type: OBSERVATIONAL
Condition:
Acu...